Literature DB >> 30063526

The Impact of Introducing a Physical Medicine and Rehabilitation Trauma Consultation Service to an Academic Level 1 Trauma Center.

Lawrence R Robinson1, Alan K H Tam, Shannon L MacDonald, Edwin Y Hanada, David Berbrayer, Abdikarim Abdullahi, Bruna G Camilotti, Homer Tien.   

Abstract

OBJECTIVE: Previous retrospective studies suggest that early physical medicine and rehabilitation (PM&R) consultation for trauma patients improves outcome and reduces acute care length of stay (LOS). There have not been controlled studies to evaluate this impact. This study assesses the impact of PM&R consultations on acute trauma patients.
DESIGN: This study compared measured outcomes before and after the introduction of a PM&R consultation service to the trauma program at a large academic hospital. The primary outcome measure was acute care LOS.
RESULTS: The 274 historical controls and 76 patients who received a PM&amp;R consultation were not different in injury severity score, age, or sex. Length of stay was not different between the two groups. However, when early (≤8 days after injury) versus late (>8 days) consults were compared, the early group had a markedly lower LOS (12 vs. 30 days, P < 0.001). When adjusted for injury severity score, an early consult was associated with an 11.8-day lower LOS (P < 0.001). The early consult group also had fewer complications and less usage of benzodiazepines and antipsychotics.
CONCLUSIONS: An acute care PM&amp;R consultation of 8 days or less after admission is associated with a shorter acute care LOS, fewer complications, and less use of benzodiazepines and antipsychotics.

Entities:  

Mesh:

Year:  2019        PMID: 30063526     DOI: 10.1097/PHM.0000000000001007

Source DB:  PubMed          Journal:  Am J Phys Med Rehabil        ISSN: 0894-9115            Impact factor:   2.159


  1 in total

1.  Management of traumatic brain injury: practical development of a recent proposal.

Authors:  Derick T Wade; Meenakshi Nayar; Javvad Haider
Journal:  Clin Med (Lond)       Date:  2022-06-15       Impact factor: 5.410

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.